Skip to main content
Clinical Trials/NCT03940040
NCT03940040
Unknown
Not Applicable

Comparing the Effect of High Flow Nasal Oxygen With Usual Care on Pulmonary Rehabilitation in COPD Patients After an Acute Exacerbation; a Pilot Randomized Controlled Trial

Changi General Hospital1 site in 1 country22 target enrollmentMay 28, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Changi General Hospital
Enrollment
22
Locations
1
Primary Endpoint
6-minute walk distance
Last Updated
5 years ago

Overview

Brief Summary

To compare the effects of high flow nasal oxygen with usual care during an outpatient 6-week pulmonary rehabilitation program after hospitalization for COPD exacerbation.

Detailed Description

This is a pilot randomized controlled trial to compare the effects of high flow nasal oxygen with usual care during an outpatient 6-week pulmonary rehabilitation program after hospitalization for COPD exacerbation.

Registry
clinicaltrials.gov
Start Date
May 28, 2019
End Date
June 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 21 years and above
  • Known diagnosis of COPD based on history AND spirometry demonstrating post bronchodilator FEV1/FVC ratio \<0.7
  • Currently admitted inpatient for an acute COPD exacerbation as the primary diagnosis
  • Fit to participate in exercise therapy as determined by both physician and physiotherapist
  • Has the mental capacity to follow instructions
  • Experience shortness of breath on exertion
  • Have decreased ability to carry out activities due to shortness of breath
  • Willing to participate in the exercise program

Exclusion Criteria

  • Uncontrolled/ unstable medical conditions such as severe chronic heart failure that make exercise unsafe
  • Pulmonary disorder other than COPD
  • Physical conditions that preclude the ability to participate in exercise or may impair exercise performance.

Outcomes

Primary Outcomes

6-minute walk distance

Time Frame: 6 weeks

It is the maximum distance walked in 6 minutes

Secondary Outcomes

  • Hospital Anxiety Depression Scale(3 weeks, 6 weeks and 1 month after completion of program)
  • COPD Assessment Test score(3 weeks, 6 weeks and 1 month after completion of program)
  • Respiratory function test(3 weeks, 6 weeks and 1 month after completion of program)
  • 6-minute walk distance(3 weeks and 1 month after completion of program)

Study Sites (1)

Loading locations...

Similar Trials